Home HealthTopics Health Centers Reference Library Search NetWellnessSearch   Advanced

Head and Neck Cancer

Targeted Therapy and Nasopharyngeal Cancer

01/06/2009

Question:

Would targeted therapy (Cetuximab) be a consideration for an elderly person with stage IV nasophyarngeal cancer?

Answer:

Cetuximab may be included in the treatment plan in patients who are elderly or who have poor performance status, either alone or in combination with other agents.

For more information:

Go to the Head and Neck Cancer health topic, where you can:

Response by:

Case Western Reserve University Panayiotis Savvides, MD
Assistant Professor
Division of Hematology and Oncology
Ireland Cancer Center
University Hospitals
School of Medicine
Case Western Reserve University
Panayiotis  Savvides, MD

Case Western Reserve University Heather Hines, RN
Medical Oncology Nurse
Ireland Cancer Center
University Hospitals
School of Medicine
Case Western Reserve University
Heather  Hines, RN